{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:49:48Z","timestamp":1791985788697,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ophtha.2011.03.030","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T03:01:43Z","timestamp":1308970903000},"page":"2279-2285","source":"Crossref","is-referenced-by-count":121,"title":["Clinical Relevance of Thyroid-Stimulating Immunoglobulins in Graves' Ophthalmopathy"],"prefix":"10.1016","volume":"118","author":[{"given":"Katharina A.","family":"Ponto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kanitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Olivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Pitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Kahaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2011.03.030_bib1","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","article-title":"Clinical practice: Graves' disease","volume":"358","author":"Brent","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2011.03.030_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08916930802031686","article-title":"Predictors of autoimmune disease: autoantibodies and beyond","volume":"41","author":"Rose","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ophtha.2011.03.030_bib3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/jc.2008-2134","article-title":"Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease","volume":"94","author":"Mizutori","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ophtha.2011.03.030_bib4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/thy.2010.1638","article-title":"The genetics of the thyroid stimulating hormone receptor: history and relevance","volume":"20","author":"Davies","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.ophtha.2011.03.030_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.autrev.2010.05.021","article-title":"Clinical review about TRAb assay's history","volume":"9","author":"Z\u00f6phel","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ophtha.2011.03.030_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/jc.2009-2405","article-title":"The thyrocyte-fibrocyte link: closing the loop in the pathogenesis of Graves' disease?","volume":"95","author":"Kahaly","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ophtha.2011.03.030_bib7","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMcp0806317","article-title":"Clinical practice","volume":"360","author":"Bartalena","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2011.03.030_bib8","series-title":"Graves' Orbitopathy: A Multidisciplinary Approach: Questions and Answers","first-page":"77","article-title":"Natural history","author":"Pearce","year":"2010"},{"key":"10.1016\/j.ophtha.2011.03.030_bib9","series-title":"Graves' Orbitopathy: A Multidisciplinary Approach: Questions and Answers","first-page":"1","article-title":"Clinical manifestations","author":"Dickinson","year":"2010"},{"key":"10.1016\/j.ophtha.2011.03.030_bib10","series-title":"Graves' Orbitopathy: A Multidisciplinary Approach: Questions and Answers","first-page":"26","article-title":"Orbit-thyroid relationship","author":"Lazarus","year":"2010"},{"key":"10.1016\/j.ophtha.2011.03.030_bib11","series-title":"Graves' Orbitopathy: A Multidisciplinary Approach: Questions and Answers","first-page":"40","article-title":"Pathogenesis","author":"Orgiazzi","year":"2010"},{"key":"10.1016\/j.ophtha.2011.03.030_bib12","first-page":"998","article-title":"Thyrotropin receptor expression in Graves' orbital adipose\/connective tissues: potential autoantigen in Graves' ophthalmopathy","volume":"83","author":"Bahn","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ophtha.2011.03.030_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/thy.1998.8.193","article-title":"Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin","volume":"8","author":"Bahn","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.ophtha.2011.03.030_bib14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2011.03.030_bib15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1089\/thy.1997.7.867","article-title":"Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor","volume":"7","author":"Tahara","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.ophtha.2011.03.030_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.autrev.2010.08.018","article-title":"Bioassays for TSH-receptor autoantibodies: an update","volume":"10","author":"Lytton","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ophtha.2011.03.030_bib17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0025-6196(12)65533-5","article-title":"Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods","volume":"63","author":"Morris","year":"1988","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ophtha.2011.03.030_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1373\/clinchem.2008.115162","article-title":"Intermethod variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves' disease and for the follow-up of Graves' ophthalmopathy","volume":"55","author":"Massart","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.ophtha.2011.03.030_bib19","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ophtha.2011.03.030_bib20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-9394(77)90140-4","article-title":"Modification of the classification of the eye changes in Graves' disease","volume":"83","author":"Werner","year":"1977","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.03.030_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/eje.1.02230","article-title":"Clinical Assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers","volume":"155","author":"Wiersinga","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ophtha.2011.03.030_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","article-title":"Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of Graves' orbitopathy","volume":"18","author":"Bartalena","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.ophtha.2011.03.030_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO","volume":"158","author":"Bartalena","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ophtha.2011.03.030_bib24","series-title":"Graves' Orbitopathy: A Multidisciplinary Approach: Questions and Answers","first-page":"66","article-title":"Diagnosis and differential diagnosis of Graves' orbitopathy","author":"Mourits","year":"2010"},{"key":"10.1016\/j.ophtha.2011.03.030_bib25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/105072502753600232","article-title":"Radiotherapy for Graves' ophthalmopathy: results at one year","volume":"12","author":"Gorman","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.ophtha.2011.03.030_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/thy.2010.0059","volume":"20","author":"Kamijo","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.ophtha.2011.03.030_bib27","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/jc.2009-2470","article-title":"A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy","volume":"95","author":"Lytton","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ophtha.2011.03.030_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2249.2010.04266.x","article-title":"Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins","volume":"162","author":"Lytton","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ophtha.2011.03.030_bib29","first-page":"776","article-title":"Linear regression analysis: part 14 of a series on evaluation of scientific publications","volume":"107","author":"Schneider","year":"2010","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.ophtha.2011.03.030_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.iop.0000235499.34867.85","article-title":"VISA classification for Graves orbitopathy","volume":"22","author":"Dolman","year":"2006","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ophtha.2011.03.030_bib31","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1089\/thy.1999.9.1175","article-title":"The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy","volume":"9","author":"Khoo","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.ophtha.2011.03.030_bib32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2265.2004.02033.x","article-title":"Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease","volume":"60","author":"Goh","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ophtha.2011.03.030_bib33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1089\/thy.2000.10.809","article-title":"Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease","volume":"10","author":"Noh","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.ophtha.2011.03.030_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","article-title":"Association of thyrotropin receptor antibodies with the clinical features of Graves' ophthalmopathy","volume":"52","author":"Gerding","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ophtha.2011.03.030_bib35","first-page":"2557","article-title":"Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor","volume":"84","author":"Valyasevi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ophtha.2011.03.030_bib36","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.4049\/jimmunol.162.8.4966","article-title":"Development of an animal model of autoimmune thyroid eye disease","volume":"162","author":"Many","year":"1999","journal-title":"J Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.ophtha.2011.03.030_bib37","first-page":"245","article-title":"Quality of life in patients suffering from thyroid orbitopathy","volume":"7","author":"Ponto","year":"2010","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.ophtha.2011.03.030_bib38","first-page":"283","article-title":"Quality of life and occupational disability in endocrine orbitopathy","volume":"106","author":"Ponto","year":"2009","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.ophtha.2011.03.030_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajo.2011.02.018","article-title":"Quality of life in a German Graves' orbitopathy population","volume":"152","author":"Ponto","year":"2011","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011002934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011002934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T14:29:39Z","timestamp":1686148179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642011002934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0161642011002934"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.03.030","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13371029.14809068","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}